Magdalena Niemira
Overview
Explore the profile of Magdalena Niemira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
591
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wozna-Wysocka M, Jazurek-Ciesiolka M, Przybyl L, Wronka D, Misiorek J, Suszynska-Zajczyk J, et al.
FASEB J
. 2024 Nov;
38(23):e70182.
PMID: 39604147
Huntington's disease (HD) is a neurodegenerative polyglutamine (polyQ) disease resulting from the expansion of CAG repeats located in the ORF of the huntingtin gene (HTT). The extent to which mutant...
2.
Tynecka M, Janucik A, Tarasik A, Zbikowski A, Niemira M, Kulczynska-Przybik A, et al.
Allergy
. 2024 Jul;
79(11):3157-3161.
PMID: 39031017
No abstract available.
3.
Ciarka A, Kunc M, Popeda M, Lacko A, Radecka B, Braun M, et al.
Contemp Oncol (Pozn)
. 2024 May;
28(1):75-83.
PMID: 38800535
Introduction: This study aimed to evaluate the impact of tumour-infiltrating lymphocytes (TILs) on the expression of immune-related genes and prognosis in single hormone receptor-positive breast cancer. Material and methods: Tumour-infiltrating...
4.
Buczynska A, Sidorkiewicz I, Niemira M, Kretowski A, Wegrzyn P, Kosinski P, et al.
Int J Mol Sci
. 2024 Mar;
25(5).
PMID: 38474143
Distinct miRNA expression patterns may reflect anomalies related to fetal congenital malformations such as spinal bifida (SB). The aim of this preliminary study was to determine the maternal miRNA expression...
5.
Niemira M, Bielska A, Chwialkowska K, Raczkowska J, Skwarska A, Erol A, et al.
Front Mol Biosci
. 2024 Mar;
11:1368372.
PMID: 38455766
According to the fifth edition of the WHO Classification of Tumours of the Central Nervous System (CNS) published in 2021, grade 4 gliomas classification includes IDH-mutant astrocytomas and wild-type IDH...
6.
Niemira M, Erol A, Bielska A, Zeller A, Skwarska A, Chwialkowska K, et al.
Sci Rep
. 2023 Nov;
13(1):19287.
PMID: 37935712
Epithelial ovarian cancer (EOC) is one of the leading cancers in women, with high-grade serous ovarian cancer (HGSOC) being the most common and lethal subtype of this disease. A vast...
7.
Sidorkiewicz I, Jozwik M, Buczynska A, Erol A, Jozwik M, Moniuszko M, et al.
Sci Rep
. 2023 Aug;
13(1):13763.
PMID: 37612452
Aberrant metabolism has been identified as a main driver of cancer. Profiling of metabolism-related pathways in cancer furthers the understanding of tumor plasticity and identification of potential metabolic vulnerabilities. In...
8.
Trubicka J, Lastowska M, Karkucinska-Wieckowska A, Niemira M, Ejmont M, Sowinska A, et al.
Folia Neuropathol
. 2023 Aug;
61(2):121-128.
PMID: 37587886
BCOR is expressed in a new brain tumour entity, i.e. 'CNS tumour with BCOR internal tandem duplication' (HGNET BCOR) but not in several other high grade paediatric brain tumours investigated....
9.
Raczkowska J, Bielska A, Kretowski A, Niemira M
Front Oncol
. 2023 Aug;
13:1209299.
PMID: 37546401
Non-small cell lung cancer (NSCLC) comprises 85% of all lung cancers and is a malignant condition resistant to advanced-stage treatment. Despite the advancement in detection and treatment techniques, the disease...
10.
Tafazoli A, Mikros J, Khaghani F, Alimardani M, Rafigh M, Hemmati M, et al.
Hum Genomics
. 2023 Jul;
17(1):62.
PMID: 37452347
Background: This pilot study aims to identify and functionally assess pharmacovariants in whole exome sequencing data. While detection of known variants has benefited from pharmacogenomic-dedicated bioinformatics tools before, in this...